Bridgewater Associates’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,020
Closed -$1.54M 1124
2026
Q1
$1.54M Sell
15,020
-3,558
-19% -$363K 0.01% 709
2025
Q4
$1.87M Sell
18,578
-3,479
-16% -$343K 0.01% 781
2025
Q3
$1.91M Buy
+22,057
New +$1.74M 0.01% 737

Other funds holding NUVL

Bridgewater Associates's NUVL Position: Q2 2026 in Review

Bridgewater Associates sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 15,020 shares — an estimated $1.54M sold.

Bridgewater Associates first reported a position in NUVL in Q3 2025 and held it in 3 quarters. The position peaked at $1.91M in Q3 2025. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Bridgewater Associates reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
  • Bridgewater Associates sold 15,020 Nuvalent shares in Q2 2026, an estimated $1.54M.
  • Bridgewater Associates first reported a position in Nuvalent in Q3 2025 and held it in 3 quarters.
  • Bridgewater Associates's Nuvalent position peaked at $1.91M in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.